Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients
- 31 January 1999
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 127 (1), 20-26
- https://doi.org/10.1016/s0002-9394(98)00286-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A 1-Year Study of Brimonidine Twice Daily in Glaucoma and Ocular HypertensionArchives of Ophthalmology (1950), 1997
- Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertensionSurvey of Ophthalmology, 1996
- Effects of Brimonidine on Aqueous Humor Dynamics in Human EyesArchives of Ophthalmology (1950), 1995
- The Cardiovascular, Pulmonary, and Ocular Hypotensive Effects of 0.2% BrimonidineArchives of Ophthalmology (1950), 1995
- Topical Timolol Decreases Plasma High-Density Lipoprotein Cholesterol LevelArchives of Ophthalmology (1950), 1990
- Systemic Effects of Medications Used To Treat GlaucomaAnnals of Internal Medicine, 1990